Company: NEOV
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001683168-25-007304
Chunk: 134

Company: NeoVolta Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 1A
Chunk 134
---
 years to resolve and we might not ultimately prevail. We cannot guarantee that
any patents, issued or pending, will provide us with any competitive advantage or will not be challenged by third parties. Moreover, the
expiration of our patents may lead to increased competition with respect to certain products.

Our industry is subject to technological
change, and our failure to continue developing new and improved products and to bring these products rapidly to market could have an adverse
impact on our business.

New products, or refinements
and improvements to our existing products, may have technical failures, delayed introductions, higher than expected production costs or
may not be well accepted by our customers. If we are not able to anticipate, identify, develop and market high quality products in line
with technological advancements that respond to changes in customer preferences, demand for our products could decline and our operating
results could be adversely affected.

Public company compliance may make it more
difficult to attract and retain officers and directors.

The Sarbanes-Oxley Act and
rules subsequently implemented by the SEC have required changes in corporate governance practices of public companies. As a public company,
we expect that these rules and regulations may make it more difficult and expensive for us to obtain director and officer liability insurance
in the future and we may be required to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same
or similar coverage. As a result, it may be more difficult for us to attract and retain qualified persons to serve on our Board of Directors
or as executive officers.

Confidentiality agreements with employees
and third parties may not prevent unauthorized disclosure of trade secrets and other proprietary information, and our inability to maintain
the confidentiality of that information, due to unauthorized disclosure or use, or other event, could have a material adverse effect on
our business. 

In addition to the protection
afforded by patents, we seek to rely on trade secret protection and confidentiality agreements to protect proprietary know-how that is
not patentable or that we elect not to patent, processes for which patents are difficult to enforce, and any other elements of our product
discovery and development processes that involve proprietary know-how, information, or technology that is not covered by patents. Trade
secrets, however, may be difficult to protect. We seek to protect our proprietary processes, in part, by entering into confidentiality
agreements with our employees, consultants, advisors, contractors and collaborators. Although we use reasonable efforts to protect our
trade secrets, our employees, consultants, advisors